Bayer is deepening its India self-care market push as the global pharmaceutical company bets on rising demand for preventive healthcare and over-the-counter wellness products to strengthen its position in one of its fastest-growing markets.
India’s pharmaceutical industry is under pressure as rising costs and an export slump squeeze drugmakers hard, impacting profits and slowing growth. Pharmaceutical companies, which have long benefited from strong overseas demand, are now facin...
India launches Alzheimer’s drug Lormalzi by Eli Lilly, offering hope for early-stage patients with treatment designed to slow cognitive decline.
Karnataka has taken a giant leap in public health governance by launching its drug monitoring portal that automatically blocks the sale of substandard medicines.
An experimental Alzheimer’s drug is advancing despite a trial miss, keeping the Tau Therapy Race alive. The Alzheimer’s drug, designed to target the tau protein linked to cognitive decline, delivered mixed mid-stage results but showed enough...
Swiss pharma giant Roche has introduced Tecentriq SC in India, a faster subcutaneous version of its blockbuster lung cancer treatment that can be administered in just seven minutes.
Patients with Heart Failure and CKD often face serious complications beyond their primary disease. One growing concern is hyperkalaemia, a condition that raises potassium levels in the blood. Doctors now view hyperkalaemia as a recurring clinical...
Roche’s blood test breakthrough for early Alzheimer’s detection is drawing global attention after the company received the CE Mark approval in Europe for its Elecsys plasma pTau217 test. The new blood test to detect Alzheimer’s is expected...
In an exclusive interview with Thiruamuthan, Assistant Editor at India Pharma Outlook, Debashis Sarkar, SVP & Head Emerging Markets, Aurobindo Pharma, discusses how Indian pharma is building biologics capabilities, balancing generics with innovation,
AIIMS, affordable epilepsy test, and safer epilepsy treatment are now at the center of a major healthcare initiative aimed at improving treatment outcomes for patients across India. The new testing facility, introduced at the Neuroscienc...
, CDSCO.jpg)